Time to abandon placebo control in pivotal phase III trials?

E-ISSN： 2051-5545|14|3|306-307

ISSN： 1723-8617

Source： World Psychiatry, Vol.14, Iss.3, 2015-10, pp. : 306-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Time to abandon placebo control in pivotal phase III trials?

World Psychiatry, Vol. 1723-8617, Iss. 3, 2015-10 ,pp. : 306-307

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

By Vollmer T. Sorensen P. Selmaj K. Zipp F. Havrdova E. Cohen J. Sasson N. Gilgun-Sherki Y. Arnold D.

Journal of Neurology, Vol. 261, Iss. 4, 2014-04 ,pp. : 773-783

Springer Publishing Company

Access to resources Recommend Favorite

Use of a placebo in clinical trials

By Emilien G. Maloteaux J. Seghers A. Charles G.

European Psychiatry, Vol. 13, Iss. 5, 1998-08 ,pp. : 254-263

Elsevier

Access to resources Recommend Favorite

Psychiatric drug trials and placebo

By Koponen Hannu Lepola Ulla

Nordic Journal of Psychiatry, Vol. 59, Iss. 4, 2005-09 ,pp. : 233-237

Informa Healthcare

Access to resources Recommend Favorite

Anticonvulsant therapy in the elderly--A need for placebo controlled trials

By Cameron H. Macphee G.J.A.

Epilepsy Research, Vol. 21, Iss. 2, 1995-06 ,pp. : 149-157

Elsevier

Access to resources Recommend Favorite